1
Ahmed et al., The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma
Expert Opin Biol Ther. 2025, 25(2), 161-173
- DOI:
http://dx.doi.org/10.1080/14712598.2025.2453524
Waissengrin & Reckamp, An evaluation of patritumab deruxtecan for the treatment of EGFR-mutated non-small cell lung cancer
Expert Opin Biol Ther. 2025, 25(6), 583-591
- DOI:
http://dx.doi.org/10.1080/14712598.2025.2507833
Hingorani, An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio
Expert Opin. Biol. Ther. 2024, 24(1-2), 31-36
- DOI:
http://dx.doi.org/10.1080/14712598.2024.2305266